Biovotion receives prestigious European eHealth award

2013/05/13

Yesterday, Biovotion was honoured with a prestigious eHealth EU SME competition award, at the eHealth week 2013 in Dublin, Ireland. Over the last six months, ten companies were selected, from more than 200 registrants, to enter the final of the EU SME eHealth competition. Biovotion was awarded the silver medal for the development of its VSM platform.

The awardees were selected by an international panel of eHealth experts, venture capital investors and industrial representatives, during the biggest European eHealth conference, bringing together more than 3000 international attendees from industry, healthcare, academia and politics, with the participation of major European political leaders.

"The team at Biovotion has been working very hard in the last few years to achieve the product level now regarded as being amongst the European leaders as a new player in the field of mHealth", says Andreas Caduff, CEO and Co-Founder of the company. "We are very pleased with this distinction, taking it as a further motivation to continue our path towards the market ".

With “consumerised healthcare” rapidly advancing and the medical device space seeing a transition towards patient home monitoring concepts, Biovotion sees its expertise and product development as instrumental in delivering solutions to this unfolding market.

Together with the continuing increase in healthcare costs, growing numbers of chronically ill patients or the number of elderly people that wish to pursue an independent life style, adequate monitoring is becoming key to tackle these challenges. With the VSM platform showing parity with standard hospital based systems today, Biovotion sees itself well positioned to provide such key elements.

Such a transition in healthcare has not only become an industry driven process but particularly has been recognised on a political and policy makers level globally, placing this topic as a top priority on the agenda of many decision makers. This was also acknowledged by both Neelie Kroes, European Commission Vice-President for the digital agenda as well as Tonio Borg, European Commissioner for Health and Consumer Affairs in their key note speeches.

Media Release: europa.eu/rapid/press-release_MEMO-13-429_en.htm

About Biovotion

The Vital Sign Monitor (VSM) is a wearable multi-sensor platform for continuous, non-invasive monitoring of physiological parameters. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing and transmission into cloud storage. The VSM1 measures the following parameters under everyday life conditions: heart rate, blood oxygenation, movement, cutaneous blood volume and perfusion, as well as skin temperature. The unique design of the optical sensors, signal processing algorithms together with a highly comfortable attachment concept ensure reliable monitoring of blood circulation in a reflection mode on freely moving individuals. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters. It has been demonstrated that the VSM platform provides vital sign data quality on par with standard hospital devices – robust, accurate and easy to use.

For further information please contact infobiovotioncom

Biovotion selected as finalist in EU SME eHealth Competition

2013/03/21

Biovotion has been selected as one of the finalists for the EU SME eHealth Competition at the World of Health IT eHealth week 2013 conference in Dublin, Ireland. Biovotion will present its VSM mHealth solution on Monday 13. May, 2013. The competition is to reward the best eHealth solution developed by a European SME.

eHealth Week 2013 - Innovative Healthcare & Well-being

eHealth Week 2013 brings together two main events: the High Level eHealth Conference co-organised by the European Commission and the Irish Presidency of the Council of the European Union, and WoHIT (World of Health IT Conference & Exhibition) organised by HIMSS Europe. The event not only brings industry partners and providers from across Europe, but also important government and regional decision makers.

The eHealth week 2013 focuses on the continuity of care from the home to hospital and back to home, demonstrating how information can flow between these different care settings. It includes topics such as patients’ empowerment and chronic disease management involving investment and business opportunities in healthcare IT.

Biovotion names company CFO

2013/02/28

Zurich, Switzerland, Feb. 28, 2013 -- Biovotion AG, the vital sign monitoring company, has announced that Mikael von Euw will become its Chief Financial Officer.

"Biovotion is very pleased to have Mikael von Euw joining our company as CFO," said Andreas Caduff, CEO of Biovotion. "Mikael's background of 20 years in investment banking and the medical device industry will bring solid support to the commercialization of our vital sign monitor platform VSM". Mikael was an executive director with the investment bank of UBS in Zurich and London, a founding partner of a medical device venture capital company and is a founding partner at Sirius Healthcare Partners, a life science corporate finance boutique. He sat on several healthcare company boards and holds a Master Degree with honour in Economics and Political Science of the University of Zurich, Switzerland.

Biovotion develops specialised wearable physiological monitoring solutions that are easy to use, robust and accurate, providing hospital like information in environments such as the home. The company has shown its ability of monitoring various physiological functions and processes, amongst them vital sign parameters with an accuracy that is on par with hospital based systems. The VSM platform is therefore particularly useful for patient home monitoring and is expected to form a central element in such future patient monitoring infrastructures.

For further information contact infobiovotioncom

Biovotion presented at CTI-Invest

2012/09/10

Biovotion was invited as one of six Swiss companies selected to present at the annual CTI-Invest conference on September, 05 in Zurich, Switzerland. CTI Invest is one of the leading financing platforms for Swiss High Tech Start up’s, presenting early as well as late stage companies. Currently, Swiss companies in the CTI Start-up coaching process or already holders of the CTI Start-up label are presented to the members. A short video of the presentation can be seen here. A full video can be made available in further follow up.

First year anniversary

2012/07/10

Biovotion just celebrated its first year anniversary and it is our pleasure to present you a short annual update that reflects on what has happened in these last 12 months. We thank those very much who have interacted with us over this time. We are looking forward to sharing further news with you in the coming months.

The main target reached: Demonstration of the ability to monitor vital signs, such as blood oxygenation under daily life conditions on par with standard hospital systems. The respective device is fully wearable, motion tolerant and allows cable free monitoring.

PDF file here to download:

Big Data - Biovotion at HealthStartup conference

2012/06/15

HealthStartup announces its III. conference to be held June, 26 in Nijmegen, The Netherlands. The theme of this edition is ‘Big Data’ and it is focused on health startups that place data at the heart of their business model and business proposition.

Big data will increasingly help revolutionise medicine and medical care. Extensive data from a large number of patients or patient groups from their daily life combined with information related to their underlying prescribed treatment, its effects and behaviour information will be of major interest to health care providers, payment organisations or the pharmaceutical industry. An essential requirement for generating reliable data during daily life is the availability of monitoring devices that allow robust, easy and accurate operation by the patient in a home environment. Biovotion will elaborate on its ability to facilitate the provision of big data, as well as present its respective wearable and movement tolerant physiological monitoring system. Biovotion will present its VSM development around its wearable platform and the continuous data to be collected from a day life environment.

 
About Biovotion

Biovotion is developing truly wearable medical devices for continuous, non-invasive physiological monitoring. The company holds extensive expertise in combining sensors, creating miniaturised, cable free multi-sensor systems, that can be easily worn on the body, allowing reliable monitoring during everyday life. Integration with cloud services provides a true mHealth environment, optimised for patient home monitoring solutions. Biovotion’s initial vital sign monitoring platform is termed VSM1.

For further information please contact infobiovotioncom

 
About HealthStartup

The health sectors are ripe for technology-driven change. The internet and related technology trends are enabling new business models and services, they are empowering consumers-patients to take a far more proactive role in taking care of their own health, and they are improving the way healthcare is practiced and organized. We think there is tremendous potential currently to create exciting new health services and to radically improve the quality, efficiency and accessibility of healthcare. That’s why we’re supporting digital health startups in Europe. Healthstartup provides an environment to create connections between the burgeoning digital startups scene and the health sectors. Within a series of events in various European cities entrepreneurs, health care professionals, policy makers and investors are being brought together. In support of these events emerging trends in digital health are being tracked, developing an extensive network of healthcare experts and decision makers in Europe and further afield.

For further details visit http://healthstartup.eu or contact Leo Exter, leohealthstartupeu.

Experiences from the eHealth week 2012 in Copenhagen

2012/05/22

Biovotion has attended a fascinating and inspiring eHealth week WoHIT conference 2012 in Copenhagen, Denmark. Earlier this year, Biovotion was elected as one of the 30 European finalists for the EU SME eHealth competition and had the opportunity to present its VSM solution for home monitoring in e.g. COPD patients.
This event is the biggest and probably most important event in the year in the arena of eHealth and indeed it has been a very useful, inspiring and impressive experience.
The eHealth week 2012 focused on the continuity of care from the home to hospital and back to home, demonstrating how information can flow between these different care settings. It included topics such as patients’ empowerment and chronic disease management involving investment and business opportunities in healthcare IT. It became evidently clear that a number of developments are about to become a “mandatory” reality particularly in patient home monitoring.
In essence politicians, reimbursement agencies and other stakeholders have placed the following message:

a) Patients need to be kept out of the hospital as much as possible

b) Patients with (multiple) chronic conditions are the biggest burden to the healthcare budget, particularly those that have repeated acute conditions

c) Appropriate monitoring will need to be available to the patient at home/daily life, meaning that home monitoring becomes key

d) (Real-time) data is needed to support outcome based treatments and to make sure to support the above a-c

Despite the fact that Biovotion’s VSM solution is not yet commercially available in the market today, Biovotion was elected as one of the top 30 European SMEs in eHealth to present its solution. The presentation can be seen here.
The presented Vital Sign Monitor (VSM) is a wearable monitoring device for continuous, non-invasive monitoring of physiological processes based on a multi-sensor concept. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing. The unique design of the optical sensors and signal processing algorithms ensure reliable monitoring of blood circulation in reflection mode during everyday life. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters.
With its VSM 1 product development Biovotion is very well positioned to deliver not only a new generation of vital sign monitors but a solution with a high degree of inter-operability to a mHealth environment.

For further information please contact: infobiovotioncom

Biovotion selected as finalist in EU SME eHealth Competition

2012/03/29

Biovotion has been selected as a finalist for the EU SME eHealth Competition at the World of Health IT eHealth week 2012 conference in Copenhagen, Denmark. Biovotion will present its VSM mHealth solution on Monday 07. May, 2012.

The provision of continuity of care and patient centric health services through the use of innovative eHealth solutions

The eHealth week 2012 focuses on the continuity of care from the home to hospital and back to home, demonstrating how information can flow between these different care settings. It includes topics such as patients’ empowerment and chronic disease management involving investment and business opportunities in healthcare IT. The Vital Sign Monitor (VSM) is a wearable monitoring device for continuous, non-invasive monitoring of physiological processes based on a multi-sensor concept. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing. The VSM measures the following parameters under everyday life conditions: heart rate, arterial and venous blood oxygenation, movement indicator, cutaneous blood volume and perfusion, as well as skin temperature. The unique design of the optical sensors and signal processing algorithms ensure reliable monitoring of blood circulation in a reflection mode on freely moving individuals. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters. Its first application will be in patients with COPD under long term oxygen therapy (LTOT).

For further information please contact infobiovotioncom

Biovotion completes proof of concept study for its VSM

2012/02/23

The VSM is a wearable monitoring device for continuous, non-invasive monitoring of physiological processes based on a multi-sensor concept. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing. The VSM measures the following parameters under everyday life conditions: heart rate, arterial and venous blood oxygenation, respiration rate, movement indicator, cutaneous blood volume and perfusion, as well as skin temperature. The unique design of the optical sensors and signal processing algorithms ensure reliable monitoring of blood circulation in a reflection mode on freely moving individuals. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters.

For further information please contact infobiovotioncom

Biovotion to present results of its wearable multi-sensor technology

2012/12/03

Biovotion announces oral presentation at the ATTD conference 2012, taking place between February 8-12, 2012 in Barcelona, Spain. Biovotion will present the latest findings of the long-term use of its miniaturised and wearable multi-sensor technology in daily life. The long-term use with its non-invasive physiological monitoring device presents one of the first ever real long-term home-use trial performed in patients, together with tight reference monitoring and log book recording. Respective results will be shown for the first time in Barcelona, demonstrating for instance the feasibility of the wearable concept for long-term use.

ATTD 2012

 

Biovotion files new patent application

2011/10/28

Biovotion has recently filed a new patent application for its proprietary and innovative vital sign monitoring technology. This patent application complements and expands on the existing Biovotion patent portfolio. The innovation is encapsulated in the application of a combination of different sensors, using state of the art signal processing routines, to yield vital sign parameters under everyday life conditions with a highly portable and wearable monitoring concept.

 

Biovotion acquires Solianis’ sensor infrastructure

2011/10/21

Biovotion announces the acquisition of the Solianis’ sensor and their related relevant technical infrastructure. This acquisition presents new business opportunities when combined with the recent acquisition of the entire Solianis IP portfolio. The availability of this IP portfolio and the respective sensors allows Biovotion to not only consider expanding the physiological monitoring platform, but also to directly benefit from previously established technology and know-how combined with the now readily available sensor technology and software.

 

Biovotion files new patent application

2011/10/28

Biovotion has recently filed a new patent application for its proprietary and innovative vital sign monitoring technology. This patent application complements and expands on the existing Biovotion patent portfolio. The innovation is encapsulated in the application of a combination of different sensors, using state of the art signal processing routines, to yield vital sign parameters under everyday life conditions with a highly portable and wearable monitoring concept.

Biovotion acquires Solianis IP

2011/10/12

Biovotion announces the acquisition of the Solianis IP portfolio. The portfolio comprises numerous granted and filed patents in the domain of algorithmic procedures, software features, mechanical set ups, sensor & hardware designs, chemical compounds, attachment concepts or considerations about combinations of multiple sensors. Most of these patents are related to physiological monitoring. Together with Biovotion’s own IP, this will allow to continue unfolding our activities within the field of physiological monitoring.

Incorporation Announcement

2011/08/15

We are happy to inform you that our time and efforts have enabled us to set up a new company.

Please read our Incorporation Announcement to learn more.

disclaimer | impressum